Use of the Skin Glue in the Placement of Central Venous Catheters Port a Catch
NCT ID: NCT03801811
Last Updated: 2019-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2018-09-05
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is possible that the surgical incision created for the insertion of the PORT may undergo complications such as: local bleeding, infections or wounds of the surgical wound.
A solution to this problem could be the application of the cyanoacrylate dermal glue on the edges of the surgical wound, after intradermal suture. The glue would have the purpose of sealing the surgical wound so as to immediately seal the skin incision with hemostatic effect and create a potential barrier against infections.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Cyanoacrylate Glue in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients: Randomised Clinical Trial (CIANO-ETI)
NCT05299060
Evaluation of Tissue Glue on PICC and Midline Catheters Insertion Sites
NCT04900740
Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients
NCT06770374
Impact of Cyanoacrylate Glue on PICC Line Dressing Care
NCT05246709
Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter
NCT01270152
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The parameters analized will be related to:
* essential patient data (identification number, gender, age, height weight)
* basic diseases
* associated diseases and risk factors
* origin of the patient (department or home)
* reason for positioning
* hemorrhagic complications detected in the first 24 hours
* hemorrhagic complications detected in the first 7 days
* non-bleeding complications detected at 7 days (local and systemic infections, wound delescence)
The data wil be transferred to an Excel worksheet, in order to conduct a descriptive analysis related to every variable
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Study of the efficacy of using skin glue in the application of Port a cath
The use of glue as a device in the implantation of central venous catheters has recently been introduced into European clinical practice. It is possible that the surgical incision created for the insertion of the PORT may be subject to complications such as: local bleeding, which if not properly treated may last even a few days, infections or surgical wound outbreaks. This possibility of bleeding occurs more easily in patients suffering from coagulation problems or when appropriate preventive measures have not been taken at the time of implantation of the device. A solution to this problem could be the application of the cyanoacrylate dermal glue on the edges of the surgical wound, after intradermal suture. The glue would have the purpose of sealing the surgical wound so as to immediately seal the skin incision with hemostatic effect and create a potential barrier against bacterial infections.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \> 18 years
Exclusion Criteria
* Cianoacrilate allergy
* Presence of bacteraemia
* Informed consent refusal
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Parma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elena Giovanna Bignami
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Ospedaliera Universitaria di Parma
Parma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Elena Giovanna Bignami, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
382/2018/DISP/AOUPR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.